Diversification of haematopoietic stem cells to specific lineages

Nature Reviews Genetics

Volumn 1, Issue 1, 2000, Pages 57-64

  Orkin, Stuart H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEBRATA;

ANIMAL; ARTICLE; CELL LINEAGE; CYTOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; PATHOLOGY;

ANIMALS; CELL LINEAGE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA;

EID: 0034303586     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35049577     Document Type: Review

References (84)

1. Weissman, I. L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287, 1442-1446 (2000).
2. Orkin, S. H. Development of the hematopoietic system. Curr. Opin. Genet. Dev. 6, 597-602 (1996).
3. Dzierzak, E. & Medvinsky, A. Mouse embryonic hematopoiesis. Trends Genet. 11, 359-366 (1995).
4. Moore, M. S. A. & Metcalf, D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br. J. Haematol. 18, 279-296 (1970).
5. Medvinsky, A. L. Samoylina, N. L., Muller, A. M. & Dzierzak, E. A. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 364, 64-66 (1993). This manuscript provides evidence that intraembryonic HSCs are present in the mouse before the time at which they are detected in the yolk sac, the test system.
6. Medvinsky, A. & Dzierzak, E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86, 897-906 (1996).
7. Cumano, A., Dieterlin-Lievre, F. & Godin, I. Lymphoid potential, probed before circulation in mouse, is restriced to caudal intraembryonic splanchnopleura. Cell 86, 907-916 (1996).
8. Cumano, A., Dieterlin-Lievre, F. & Godin, I. The splanchnopleura/AGM region is the prime site for the generation of multipotent hemopoeitic precursors, in the mouse embryo. Vaccine 18, 1621-1623 (2000).
9. Godin, I., Dieterlin-Lievre, F. & Cumano, A. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8. 5 days postcoitus. Proc. Natl Acad. Sci. USA 92, 773-777 (1995).
10. Yoder, M. C. et al. Characterization of definitive lympho-hemapoietic stem cells in the day 9 murine yolk sac. Immunity 7, 335-344 (1997).
11. Yoder, M. C. & Hiatt, K. Murine yolk sac and bone marrow hemapoietic cells with high proliferative potential display different capacities for producing colony-forming cells ex vivo. J. Hematother. Stem Cell Res. 8, 421-430 (1999).
12. Pardanaud, L., Yassine, F. & Dieterlin-Lievre, F. Relationship between vasculogenesis, angionesis, and haemapoiesis during avian ontogeny. Development 105, 473-485 (1989).
13. Jaffredo, T., Gautier, R., Eichmann, A. & Dieterlin-Lievre, F. Intraaortic hemopoeitic cells are derived from endothelial cells during ontogeny. Development 125, 4575-4583 (1998). This paper reported data in favour of the origin of haematopoietic cells from the vasculature. This work supports the concept of 'haemogenic endothelium'.
14. Pardanaud, L. & Dieterlin-Lievre, F. Manipulation of the angiopoietic/hemagiopoietic commitment in the avian embryo. Development 126, 617-627 (1999).
15. Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. & Keller, G. A common precursors for hematopoietic and endothelial cells. Development 125, 725-732 (1998). Through in vitro differentiation of embryonic stem cells, this paper provides evidence for the existence of the elusive haemangioblast.
16. - hemapoeitic cells in the early human embryo. Blood 87, 67-72 (1996).
17. North, T. et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126, 2563-2575 (1999).
18. Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA 93, 3444-3449 (1996).
19. Okuda, T., Deursen, J. v., Hiebert, S. W., Grosveld, G. & Downing, J. R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
20. DeBruijn, M. F. T. R., Speck, N. A., Peeters, M. C. E. & Dzierzak, E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 19, 2465-2474 (2000).
21. Nishikawa, S.-I. et al. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity 8, 761-769 (1998).
22. Nishikawa, S. I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. & Kodama, H. Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE-cadherin1 cells at a diverging point of endothelial and hemopoietic lineages. Development 125, 1747-1757 (1998).
23. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I. L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197 (2000).
24. Phillips, R. L. et al. The genetic program of hematopoietic stem cells. Science 288, 1635-1640 (2000).
25. Socolovsky, M., Lodish, H. F. & Daley, G. Q. Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors. Proc. Natl Acad. Sci. USA 95, 6573-6575 (1998).
26. Stoffel, R. et al. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. Proc. Natl Acad. Sci. USA 96, 698-702 (1999).
27. Orkin, S. H. in Molecular Biology of B-cell and T-cell Development (eds Monroe, J. G. & Rothenberg, E. V.) 41-54 (Humana, Totowa, New Jersery, 1998).
28. Weintraub, H. et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761-766 (1991).
29. Kulessa, H., Frampton, J. & Graf, T. GATA-1 reprograms avian myelomonocytic cells into eosinophils, thromboblasts and erythroblasts. Genes Dev. 9, 1250-1262 (1995). This paper reports the ability of GATA-1 to alter the phenotype of haematopoietic cells. In contrast to the action of myogenic factors in recipient cells, GATA-1 converts progenitors to three different lineages, depending on the concentration at which it is expressed.
30. Visvader, J. E., Elefanty, A. G., Strasser, A. & Adams, J. M. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J. 11, 4557-4564 (1992).
31. Visvader, J. E., Crossley, M., Hill, J., Orkin, S. H. & Adams, J. M. The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol. Cell. Biol. 15, 634-641 (1995).
32. Visvader, J. & Adams, J. M. Megakaryocytic differentiation induced in 4168 myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood 82, 1493-1501 (1993).
33. Nerlov, C., McNagny, K. M., Doderlein, G., Kowenz-Leutz, E. & Graf, T. Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev. 12, 2413-2423 (1993).
34. Nerlov, C. & Graf, T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412 (1998).
35. Kelly, L. M. et al. MafB is an inducer of monocytic differentiation. EMBO J. 19, 1987-1997 (2000).
36. McDevitt, M. A., Shivdasani, R. A., Fujiwara, Y., Yang, H. & Orkin, S. H. A 'knockdown' mutation created by ciselement gene targeting reveals the dependence of red blood cell maturation on the level of transcription factor GATA-1. Prcc. Natl Acad. Sci. USA 94, 6781-6785 (1997).
37. DeKoter, R. P. & Singh, H. Graded levels of PU.1 specify B lymphocyte and macrophage cell fates. Science 288, 1439-1441 (2000).
38. Lebestky, T., Chang, T., Hartenstein, V. & Banerjee, U. Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science 288, 146-149 (2000).
39. Adams, B. et al. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6, 1589-1607 (1992).
40. Urbanek, P., Wang, Z.-Q., Fetka, I., Wagner, E. R. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901-912 (1994).
41. -/- haematopoietic cells is examined. Evidence is provided to show that Pax5 is required to suppress other lineages and direct B-lymphoid differentiation.
42. Rolink, A. G., Nutt, S. L., Melchers, F. & Busslinger, M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401, 603-606 (1999).
43. Busslinger, M., Nutt, S. L. & Rolink, A. G. Lineage commitment in lymphopoiesis. Cuir. Opin. Immunol. 12, 151-158 (2000).
44. Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
45. Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
46. Pevny, L. et al. Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349, 257-260 (1991). In this 'classic* paper, the requirement for a lineage-restricted haematopoietic transcription factor for differentiation is documented through analysis of chimaeras generated with gene-targeted embryonic stem cells.
47. Shivadasani, R. A., Fujiwara, Y., McDevitt, M. A. & Orkin, S. H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16, 3965-3973 (1997).
48. Fujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C. & Orkin, S. H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 12355-12358 (1996).
49. McKercher, S. R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658 (1996).
50. Scott, E. W., Simon, M. C., Anastasi, J. & Singh, H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265, 1573-1577 (1994).
51. Moreau-Gachelin, F. et al. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16, 2453-2463 (1996).
52. Moreau-Gachelin, F. et al. The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell 61, 1166 (1990).
53. Rekhtman, N., Radparvar, F., Evans, T. & Skoultchi, A. I. Direction interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13, 1398-1411 (1999). This paper presents strong evidence to illustrate that direct antagonism between these transcription factors is critical for the development of different lineages. This work is complemented and extended by Refs 54-56.
54. Zhang, P. et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl Acad. Sci. USA 96, 8705-8710 (1999).
55. Nerlov, C., Querfurth, E., Kulessa, H. & Graf, T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95, 2543-2551 (2000).
56. Zhang, P. et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA-binding. Blood (in the press).
57. Querfurth, E. et al. Antagonism between C/EBPβ and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. (in the press).
58. Tsang, A. C. et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90, 109-119 (1997). This paper was the first to describe a specific cofactor that modulates the function of GATA-1 in transcription.
59. Tsang, A. P., Fujiwara, Y., Horn, D. B. & Orkin, S. H. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev. 12, 1176-1188 (1998).
60. Deconinck, A. E. et al. FOG acts as a repressor of red blood cell development in Xenopus. Development 127, 2031-2040 (2000).
61. Fox, A. H. et al. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. EMBO J. 18, 2812-2822 (1999).
62. Georgopoulos, K. et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156 (1994).
63. Georgopoulos, K., Moore, D. D. & Defler, B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258, 808-812 (1992).
64. Wang, J. H. et al. Selective detects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537-549 (1996).
65. Koipally, J. & Georgopoulos, K. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J. Biol. Chem. 275, 19594-19602 (2000).
66. Eberhard, D., Jimenez, G., Heavy, B. & Busslinger, M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292-2303 (2000).
67. Sieweke, M. H., Tekotte, H., Frampton, J. & Graf, T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 84, 49-60 (1996).
68. Maitra, S. & Atchison, M. BSAP can repress enhancer activity by targeting PU.1 function. Mol. Cell. Biol. 20, 1911-1922 (2000).
69. Jimenez, G., Griffiths, S. D., Ford, A. M., Greaves, M. F. & Enver, T. Activation of the β-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl Acad. Sci. USA 89, 10618-10622 (1992).
70. Hu, M. et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11, 774-785 (1997). Single-cell RT-PCR was used in this study to show that multipotential progenitor cells contain transcripts usually associated with different lineages.
71. Tsai, S.-F., Strauss, E. & Orkin, S. H. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 5, 919-931 (1991).
72. Chen, H. et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 19, 1549-1560 (1995).
73. Nutt, S. L et al. Independent regulation of the two Pax5 alleles during B-cell development. Nature Genet. 21, 390-395 (1999).
74. Nutt, S. L. & Busslinger, M. Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes? Biol. Chem. 380, 601-611 (1999).
75. Enver, T. & Greaves, M. Loops, lineage, and leukemia. Cell 94, 9-12 (1998).
76. Downing, J. R. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br. J. Haematol. 106, 296-308 (1999).
77. Jackson, K. A., Mi, T. & Goodell, M. A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl Acad. Sci., USA 96, 14482-14486 (1999).
78. Gussoni, E. et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390-394 (1999). These two papers show that muscle progenitor cells seem to contribute to haematopoiesis and, conversely, that haematopoietic progenitors give rise to muscle In transplanted mice. In Ref. 77, it is shown that in vitro culture of muscle progenitors seems to augment haematopoietic reconstitution.
79. Wood, H. B., May, G., Healy, L. Enver, T. & Morriss-Kay, G. M. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90, 2300-2311 (1997).
80. Bjornson, C. R., Riete, R. L., Reynolds, B. A., Magli, M. C. & Vescovi, A. L Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 283, 534-537 (1999).
81. Clarke, D. L. et al. Generalized potential of adult neural stem cells. Science 288, 1660-1663 (2000). These two papers indicate that adult neural stem cells have diverse developmental potentials when introduced into mice, chicken embryos, or examined in vitro in embryoid bodies.
82. Petersen, B. E. et al. Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170 (1999).
83. Theise, N. D. et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31, 235-240 (2000).
84. Blau, H. M. & Baltimore, D. Differentiation requires continuous regulation. J. Cell Biol. 112, 781-783 (1991).